Eiko LifeSciences Ltd. (EIKO.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-352.0%

-₹132.29

vs ₹52.50 price

Levered DCF

-₹240.60

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

—

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	15.94×	32.7×	74.73×	75.57×	76.54×	37.08×	-11.96×	-51.47×
P/B	1.07×	1.21×	1.11×	1.99×	1.88×	1.82×	7.74×	4.63×
P/S	1.39×	1.83×	2×	3.06×	2.06×	1.85×	2.19×	5.32×
EV / EBITDA	7.61×	15.11×	24×	31.98×	44.25×	20.93×	-5.4×	-35.87×
Gross margin	21.7%	13.3%	8.8%	12.8%	10.5%	10.1%	1.2%	10.2%
Operating margin	12.2%	5.4%	4.0%	5.7%	5.6%	6.6%	0.1%	9.4%
Net margin	8.5%	5.6%	2.7%	4.0%	2.7%	5.0%	-18.3%	-10.4%
Current ratio	3.08×	5.25×	20.56×	7.76×	2.24×	2.7×	0.54×	1.02×
Debt / equity	0.07×	0.05×	0×	0×	0.16×	0.15×	0.55×	0.28×
Interest coverage	19.48×	13.23×	7.99×	7.23×	3.94×	9.33×	0.15×	2.31×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	6.5%	3.7%	1.5%	2.6%	2.5%	4.9%	-64.7%	-9.0%
Return on invested capital	6.3%	2.5%	1.7%	2.7%	3.3%	4.2%	0.3%	5.1%
Return on assets	5.0%	3.2%	1.4%	2.5%	2.0%	3.7%	-15.8%	-4.8%
Free cash flow yield	3.1%	-10.7%	-13.2%	6.8%	-14.6%	-3.6%	-2.5%	-0.2%
Earnings yield	6.1%	3.1%	1.3%	1.3%	1.3%	2.7%	-8.4%	-1.9%
Enterprise value	₹643.8M	₹598.5M	₹429.3M	₹578.7M	₹582.2M	₹205.6M	₹243.9M	₹240.6M
Net debt / EBITDA	-1.05×	-2.28×	-7.46×	-0.31×	3.35×	-2.29×	-0.35×	-1.87×
Cash conversion cycle (days)	64	132	199	133	128	41	21	160